Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Артериальная гипертония у пожилых: особенности течения и выбор терапии
Артериальная гипертония у пожилых: особенности течения и выбор терапии
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Шальнова С.А., Баланова Ю.А., Константинов В.В. и др. Артериальная гипертония: распространенность, осведомленность, прием антигипертензивных препаратов и эффективность лечения среди населения Российской Федерации. РКЖ. 2006; 4: 45–50.
2. Fletcher A. Epidemiology of Hypertension in the elderly. J Hypertens 1994; 12 (Suppl. 6).
3. Ольбинская Л.И., Морозова Т.Е. Фармакотерапия гипертонической болезни. Руководство. М.: Русский врач. 2002.
4. 2003 Guidelines for the Management of Arterial Hypertension. J Hypertens 2003; 21: 1011–53.
5. Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–87.
6. Hypertension. The clinical management of primary hypertension in adults. Clinical Guideline 2011; 127. Methods, evidence, and recommendations. Published by the National Clinical Guideline Centre at The Royal College of Physicians. London, NW1 4BT, National Clinical Guideline Centre 2011.
7. Диагностика и лечение артериальной гипертонии. Рекомендации РМОАГ/ВНОК, 4-й пересмотр. 2010.
8. Gosse Ph, Sheridan D, Zannad F et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1,5 mg versus enalapril 20 mg: the LIVE Study. J Hypertension 2000; 18: 1465–75.
9. Marre M, Garcia-Puig J, Kokot F et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR study. J Hypertension 2004; 22: 1613–22.
10. Тhe HYVET Study Group. Treatment of Hypertension in Patients 80 Years of Age or Older. N Engl J Med 2008; 358.
11. Kostis JB, Wilson AC, Fruedenberger RS. Long term effect of diuretic based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005; 95: 29–35.
12. Marre M, Garcia-Puig J, Kokot F et al. Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes. Am J Hypertension 2007; 20: 90–7.
13. Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension. Drugs Safety 2001; 24: 1155–65.
14. Peters R, Beckett N, Forette F et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008; 7: 683–9.
15. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ 2012; 344: d7541 doi: 10.1136/bmj.d7541 (Published 4 January 2012).
16. Bulpitt CJ, Beckett NS, Peters R et al. Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET). J Human Hypertens 2011; 1–7.
2. Fletcher A. Epidemiology of Hypertension in the elderly. J Hypertens 1994; 12 (Suppl. 6).
3. Ольбинская Л.И., Морозова Т.Е. Фармакотерапия гипертонической болезни. Руководство. М.: Русский врач. 2002.
4. 2003 Guidelines for the Management of Arterial Hypertension. J Hypertens 2003; 21: 1011–53.
5. Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–87.
6. Hypertension. The clinical management of primary hypertension in adults. Clinical Guideline 2011; 127. Methods, evidence, and recommendations. Published by the National Clinical Guideline Centre at The Royal College of Physicians. London, NW1 4BT, National Clinical Guideline Centre 2011.
7. Диагностика и лечение артериальной гипертонии. Рекомендации РМОАГ/ВНОК, 4-й пересмотр. 2010.
8. Gosse Ph, Sheridan D, Zannad F et al. Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1,5 mg versus enalapril 20 mg: the LIVE Study. J Hypertension 2000; 18: 1465–75.
9. Marre M, Garcia-Puig J, Kokot F et al. Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR study. J Hypertension 2004; 22: 1613–22.
10. Тhe HYVET Study Group. Treatment of Hypertension in Patients 80 Years of Age or Older. N Engl J Med 2008; 358.
11. Kostis JB, Wilson AC, Fruedenberger RS. Long term effect of diuretic based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005; 95: 29–35.
12. Marre M, Garcia-Puig J, Kokot F et al. Efficacy of indapamide SR compared with enalapril in elderly hypertensive patients with type 2 diabetes. Am J Hypertension 2007; 20: 90–7.
13. Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension. Drugs Safety 2001; 24: 1155–65.
14. Peters R, Beckett N, Forette F et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008; 7: 683–9.
15. Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ 2012; 344: d7541 doi: 10.1136/bmj.d7541 (Published 4 January 2012).
16. Bulpitt CJ, Beckett NS, Peters R et al. Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET). J Human Hypertens 2011; 1–7.
Авторы
Т.Е.Морозова
ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М.Сеченова Минздрава РФ
ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М.Сеченова Минздрава РФ
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.